Arabesque Asset Management LTD Amgen Inc Transaction History

Arabesque Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3.56 Million - $4.53 Million	15,556 New	15,556 $4.09 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $1.58 Million - $1.76 Million	-6,865 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.51 Million - $1.67 Million	6,865 New	6,865 $1.66 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $200,156 - $222,590	-853 Closed	0 $0
Q2 2020 Oct 22, 2020	BUY	$197.81 - $242.74 $168,731 - $207,057	853 New	853 $201,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.